FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression-Reference-Cited by-同舟云学术

FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression

Published:2019-08-02 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Tong Jiafeng¹,Shen Ying²,Chen Xi³,Wang Renjie⁴,Hu Ye²,Zhang Xu¹,Zhang Zhenghua⁵,Han Li¹

Affiliation:

1. Department of Traditional Chinese Medicine, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China

2. Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai TCM University, Shanghai 200071, P.R. China

3. Department of Oncology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China

4. Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, P.R. China

5. Department of Oncology, Jing'an District Central Hospital of Shanghai (Huashan Hospital,Fudan University, Jing'an Branch), Shanghai 200040, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FKBP3, a poor prognostic indicator, promotes the progression of LUAD via regulating ferroptosis and immune infiltration;Medicine;2024-06-28

2. Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer;Translational Oncology;2024-02

3. Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer;Molecular Oncology;2024-01-25

4. FKBP3 aggravates the malignant phenotype of diffuse large B‐cell lymphoma by PARK7‐mediated activation of Wnt/β‐catenin signalling;Journal of Cellular and Molecular Medicine;2023-11-21

5. Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?;Pharmacological Research;2023-10